Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

175P - Lactobacillus paracasei ZJUZ2-3 Inhibits the gastric tumorigenesis by inhibit NF-κB pathway via 3-IAA

Date

07 Dec 2024

Session

Poster Display session

Presenters

Rui Yang

Citation

Annals of Oncology (2024) 35 (suppl_4): S1450-S1504. 10.1016/annonc/annonc1688

Authors

R. Yang1, Y. Yang1, L. Teng2

Author affiliations

  • 1 Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, 311121 - Hangzhou/CN
  • 2 Surgical Oncology, The First Affiliated Hospital of Medical School of Zhejiang University, 310003 - Hangzhou/CN

Resources

This content is available to ESMO members and event participants.

Abstract 175P

Background

Lactobacillus paracasei is known to confer health benefits to humans. Based on our previous 16s rRNA sequencing data, Lactobacillus paracasei was depleted in gastric tumor tissues. Here, we aimed to investigate whether this bacteria could act as a prophylactic for gastric cancer (GC).

Methods

Lactobacillus paracasei ZJUZ2-3 (L.paracasei ZJU2-3) was isolated from a GC patient normal tissues with verification by whole genome sequencing. The antitumor effects of L. paracasei ZJUZ2-3 were assessed in cultured gastric cancer cells and in nude mice models of subcutaneous injected GC cell. The tumor-suppressive metabolite produced by L. paracasei ZJUZ2-3 was identified by ELISA.

Results

L. paracasei was depleted in tumor tissues of patients with GC. A new L. paracasei strain was isolated from normal tissues of a GC patient and nomenclated as L. paracasei ZJUZ2-3. We found that L. paracasei ZJUZ2-3 introtumoral injection suppressed GC tumourigenesis in nude mice. Coincubation with L. paracasei ZJUZ2-3 or its conditioned medium promote the proliferation of GC cells. However, heat-killed L. paracasei ZJUZ2-3 lost its tumor-supressive effect. Indole-3-acetic acid (IAA) was identified as the critical metabolite produced by L. paracasei ZJUZ2-3, and was increased in the GC cells supernatant of cocultrued with L. paracasei ZJUZ2-3 detected by ELISA. IAA metabolited by L. paracasei ZJUZ2-3 inhibited cell proliferation, lowered colony formation of cultured GC cells and inhibit the subcutaneous tumor in nude mice. As aryl hydrocarbon receptor (AHR) ligand, IAA can activate AHR competitively bind MTDH to inhibit its phosphorylation, thus inhibit GC cells nuclear factor kB (NF-kB) signaling pathway. Consistently, when the AHR was inhibited or knockdown, the antitumor effect of IAA was impaired.

Conclusions

L. paracasei ZJUZ2-3 is a novel prophylactic for GC prevention in vitro and in vivo. The tumor-suppressive effect of L. paracasei ZJUZ2-3 is mediated by its metabolite IAA.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

The National Natural Science Foundation.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.